Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, DIS

ImageSoft Launches SafeEncounter, a New Product to Assist in Identifying and Returning Wandering Members of the Community


A centralized digital database for first responders to identify and assist citizens with intellectual disabilities who wander from home.

ROYAL OAK, Mich., March 31, 2022 /PRNewswire-PRWeb/ --ImageSoft has released the newest product in its family of digital solutions. SafeEncounter provides law enforcement and other first responders with a secure centralized database of vulnerable members of the community. The company hopes the solution will be implemented across the country to provide protection to those most at-risk.

SafeEncounter is an online, highly-secure platform that involves elective participation by loved ones of vulnerable dependents. The dependent's family can create a profile including name, age, sex, physical description, information about any medical conditions, contact information, photos, and more. These profiles are stored in the database, accessible to only those authorized agencies whom the submitter gave permissions. When a first responder arrives at a scene and faces an individual who has trouble communicating, is disoriented, or otherwise unable to engage, they can bring up SafeEncounter on their patrol car laptop to identify the person, reach their family, and respond to the call in the safest and most appropriate manner.

SafeEncounter comes equipped with a mapping feature that displays all registered profiles in a geographic area. Other unique features include:

 

President of ImageSoft, Crystal Iverson, spoke of SafeEncounter: "This is a passion project for everyone involved. We all know someone affected by cognitive disabilities or impairments, so SafeEncounter really hits home with a lot of folks. When we were developing the platform, we'd share stories about our friends and family members who could benefit from the additional peace of mind SafeEncounter offers. Being so closely tied to the purpose behind our product made us want to get it out in the community as quickly as we could. We hope this is going to help protect a lot of vulnerable people, and the incredible first responders who assist in emergencies."

In the initial release, SafeEncounter is designed for law enforcement and those individuals who meet a specific set of criteria. Intellectual disabilities, communication problems, and developmental issues are top priority at the moment. Qualifying conditions include Alzheimer's, Dementia, Autism, Schizophrenia, Severe Bipolar Disorder, Down's Syndrome, non-verbal individuals, and those with other cognitive impairments. These individuals are most prone to wandering, and typically have a hard time communicating who they are and where their family is for a safe return. Police can utilize SafeEncounter when typical communication with these individuals is impossible.

About ImageSoft

ImageSoft, Inc. believes in helping government agencies serve constituents better by digitally transforming their operation. Since 1996, ImageSoft's technology and OnBase® by Hyland's document management and workflow solutions have increased productivity and public satisfaction, saving time and money for state and local agencies. We have deployed solutions across government agencies, including justice and public safety, finance and administration, planning and public works, health, and housing and human services. ImageSoft is a Platinum Partner of Hyland, Inc. Headquartered in Royal Oak, Michigan, ImageSoft serves customers across the U.S. and Canada.

For more information about ImageSoft, visit the website at http://www.imagesoftinc.com/.

Media Contact

Molly Berard, ImageSoft, (401)257-9918, [email protected]

 

SOURCE ImageSoft


These press releases may also interest you

at 20:14
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 19:30
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ("agilon" or the "Company").  This action, captioned Hope v. agilon health, inc., et...

at 18:00
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...



News published on and distributed by: